Gangyong Wu

Gangyong Wu

Auto-generated profile, based on publicly available information

Gangyong Wu

Department of Cardiology, The 904th Hospital of Joint Logistic Support Force of PLA, Wuxi, People’s Republic of China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2023 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
YLYehong Liu
Yehong Liu
JLJie Liu
Jie Liu
LLLongqun Liu
Longqun Liu
SCShaoqing Cao
Shaoqing Cao
TJTianhui Jin
Tianhui Jin
GZGang-jun Zong
Gang-jun Zong
Aim: Reducing the high morbidity and mortality of ST-segment elevation myocardial infarction (STEMI) and improving patient prognosis remains a major global challenge. This study aimed to explore whether dynamic fluctuations in biomarkers are valuable predictors of prognosis in patients with STEMI. Methods: This study included 216 patients with STEMI. Blood routine tests were performed on admission, 12 h after percutaneous coronary intervention (PCI), and at discharge. Systemic immune-inflammation index (SII), systemic inflammatory response index (SIRI), and pan-immune-inflammation-value (PIV) serum immune-inflammatory markers were calculated. The Cox proportional hazard model was used to assess the factors independently associated with the prognosis of STEMI. The optimal cutoff values for the inflammatory markers were calculated. Results: Eighty-five (39.35%) of the 216 patients had major adverse cardiovascular events (MACEs) during the 1-year follow-up. Most were male (81.18%) with a median age of 64 years (interquartile, 55– 69.5). Killip class ≥ II on admission (hazard ratio [HR], 1.859; 95% CI, 1.169– 2.957; P = 0.009), total stent length (HR, 1.016; 95% CI, 1.003– 1.029; P = 0.019), values of SIRI at 12 h after PCI (HR, 1.079; 95% CI, 1.050– 1.108; P < 0.001), and the Gensini score (HR, 1.014; 95% CI, 1.007– 1.022; P < 0.001) were independently associated with an increased risk of MACEs. Compared with SII, SIRI and PIV calculated at various time points and dynamically fluctuating changes, SIRI (cutoff value, 4.15; 95% CI, 0.701– 0.819; P < 0.001) and PIV (cutoff value, 622.71; 95% CI, 0.674– 0.796; P < 0.001) at 12 h after PCI showed the best efficacy for the prognosis of STEMI. Conclusion: Our study provides relevant evidence to the notion that SIRI or PIV at 12 h after PCI may be more accurate and economical predictors of long-term adverse prognosis in patients with STEMI.


10 January 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
ZWZu-Fei Wu
Zu-Fei Wu
STSi-Xiao Tao
Si-Xiao Tao
WSWen-Tao Su
Wen-Tao Su
SCShi Chen
Shi Chen
BXBai-Da Xu
Bai-Da Xu
GWGang-Yong Wu
Gang-Yong Wu
Objective: This study aims to develop a novel risk assessment tool for coronary artery disease (CAD) based on data of patients with chest pain in outpatient and emergency department, thereby facilitating the effective identification and management of high-risk patients. Methods: A retrospective analysis was conducted on patients hospitalized for chest pain. Patients were divided into a control group and a CAD group based on angiographic results. Logistic regression was used to identify factors associated with CAD, and R-Studio was utilized to construct the CAD risk prediction model. Results: Multivariate logistic regression analysis indicated that age, gender, diabetes, ECG (electrocardiogram) ST-T changes, neutrophils (NE), coronary artery calcification (CAC), and typical chest pain were independent factors associated with CAD. Based on the results of multifactorial logistic analysis, the CAD risk prediction model built with R-Studio had a highest C-index of 0.909, and a validation cohort C-index of 0.897, demonstrating excellent predictive ability. Decision Curve Analysis showed that the model significantly outperformed others in terms of clinical net benefit. Conclusion: The present study successfully developed a CAD risk assessment model based on Chinese population. This novel model could be used to assess CAD risk in patients with chest pain, optimize clinical decision making, and improve patient outcomes, regardless of whether it is applied in large hospitals or resource-limited Community Healthcare Center.

1 August 2023 in Therapeutics and Clinical Risk Management
Verified
Journal Article
Open access
PDF file
ZWZu-Fei Wu
Zu-Fei Wu
WSWen-Tao Su
Wen-Tao Su
SCShi Chen
Shi Chen
BXBai-Da Xu
Bai-Da Xu
GZGang-Jun Zong
Gang-Jun Zong
XMXiao-Lin Ma
Xiao-Lin Ma
Objective: To investigate the correlation between serum parathyroid hormone (PTH) levels and in-hospital major adverse cardiovascular events (MACE) in patients with acute ST-segment elevation myocardial infarction (STEMI) after primary percutaneous coronary intervention (PCI), and establish a risk prediction model based on parameters such as PTH for in-hospital MACE. Methods: This observational retrospective study consecutively enrolled 340 patients who underwent primary PCI for STEMI between January 2016 and December 2020, divided into a MACE group (n=92) and a control group (n=248). The least absolute shrinkage and selection operator (LASSO) and logistic regression analyses were used to determine the risk factors for MACE after primary PCI. The rms package in R-studio statistical software was used to construct a nomogram, to detect the line chart C-index, and to draw a calibration curve. The decision curve analysis (DCA) method was used to evaluate the clinical application value and net benefit. Results: Correlation analysis revealed that PTH level positively correlated with the occurrence of in-hospital MACE. Receiver operating characteristic curve analyses revealed that PTH had a good predictive value for in-hospital MACE. Multivariate logistic regression analysis indicated that Killip class II–IV, and FBG were independently associated with in-hospital MACE after primary PCI. A nomogram model was constructed using the above parameters. The model C-index was 0.894 and the calibration curve indicated that the model was well calibrated. The DCA curve suggested that the nomogram model was better than TIMI score model in terms of net clinical benefit. Conclusion: Serum PTH levels in patients with STEMI are associated with in-hospital MACE after primary PCI, and the nomogram risk prediction model based on PTH demonstrated good predictive ability with obvious clinical practical value.

26 July 2018 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
GWGang‑Yong Wu
Gang‑Yong Wu
TWTing Wu
Ting Wu
BXBai‑Da Xu
Bai‑Da Xu
YSYi‑Cheng Shi
Yi‑Cheng Shi
ZCZhi‑Yuan Cheng
Zhi‑Yuan Cheng
GZGang‑Jun Zong
Gang‑Jun Zong
The present study investigated the role of parathyroid hormone (PTH) in non‑ischemic cardiomyopathy (CM) and its underlying mechanism. A total of 30 Sprague‑Dawley male rats were randomly divided into a control group (n=6) and an experimental group (n=24). To induce CM in the rats of the experimental group, 2 mg/kg Adriamycin (ADR) was administered intraperitoneally with 5 equal injections every third day followed by 5 weekly injections resulting in a cumulative dose of 20 mg/kg. Following establishment of the model, rats in the experimental group were subdivided into a PTH‑untreated CM group that received daily normal saline subcutaneous injections for 7 days and three treated CM groups that received daily subcutaneous injections of 5, 10, or 20 µg/kg of recombinant PTH for 7 days. Rats in the control group accordingly received intraperitoneal and subcutaneous injections of normal saline. Blood sample analysis revealed that B‑type natriuretic peptide (BNP), troponin T, C‑reactive protein (CRP), creatinine and phosphorus concentrations were increased in the PTH‑untreated CM group compared with that in the control group, whereas PTH and calcium concentrations were decreased. Administration of PTH dose‑dependently decreased BNP, CRP, creatinine and phosphorus levels, and increased PTH and calcium levels. Notably, there were significant differences in PTH, BNP, troponin T, CRP, creatinine, calcium, and phosphorus levels among the rats in the five groups (P<0.01). Cardiac ultrasonography results indicated that the left ventricular ejection fraction (LVEF) was significantly decreased in rats treated with ADR compared with the rats from the control group (P<0.01). However, the LVEF gradually recovered with elevated PTH treatment doses. The overall differences of LVEF and left ventricular end‑systolic volume in the five experimental groups were statistically significant (P0.05). Immunohistochemical staining and western blot analysis using an anti‑PTH polyclonal antibody was performed to evaluate the protein expression levels of PTH in myocardial tissues. The mRNA expression levels of PTH and BNP were measured using reverse transcription‑quantitative polymerase chain reaction. The results demonstrated that the mRNA and protein expression levels of PTH in myocardial tissues were significantly decreased in ADR‑treated rats compared with the levels in the control group rats. Injection of recombinant PTH significantly increased PTH expression and reduced BNP expression in dose‑dependent manners (P<0.05). These findings demonstrated that PTH can improve cardiac function in rats with ADR‑induced CM, suggesting a potential therapeutic application for PTH in non‑ischemic CM.

3 December 2024 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
ZWZufei Wu
Zufei Wu
SWSu Wentao
Su Wentao
SCShi Chen
Shi Chen
BXBai Da Xu
Bai Da Xu
GZGang Jun Zong
Gang Jun Zong
GWGang-Yong Wu
Gang-Yong Wu
Backgroud: Coronary slow flow (CSF) is a common phenomenon of coronary microcirculation dysfunction, and is closely related to elevated blood glucose and fibrinogen (FIB) levels. However, whether immediate blood glucose and FIB levels affect coronary blood flow during primary percutaneous coronary intervention (PCI) remains unclear.Objective: To explore the correlation between admission blood glucose (ABG), fibrinogen (FIB) and slow blood flow during primary PCI for acute ST segment elevation myocardial infarction (STEMI).Methods: A total of 497 patients who underwent coronary angiography in the cardiology department of the 904th Hospital of the Joint Logistics Support Force from December 2018 to December 2022 due to STEMI were selected consecutively, and then were divided into two groups based on whether slow blood flow occurred during primary PCI: slow blood flow group (n = 117) and control group (n = 380). Detecting the ABG, FIB and other indicators of patients in each group, and using logistic regression analysis and receiver operating characteristic (ROC) curve to analyze independent risk factors for slow blood flow during primary PCI, and further evaluating the prognosis of patients.Results: The levels of ABG and FIB in patients with slow blood flow were significantly higher than those in the control group (P < 0.05). The results of multivariate logistic regression analysis suggested that FIB and ABG were independent risk factors for slow blood flow during primary PCI (both P < 0.05). ROC curve analysis showed that ABG, FIB, and their combination all had predictive value for slow blood flow during primary PCI (all P < 0.05), and the area under the curve (AUC) of the combined indicator was higher than that of any single indicator, with statistical significance (P < 0.05). KM curve analysis suggested that the prognosis of patients in slow blood flow group were poor.Conclusion: Both elevated ABG and FIB could predict slow blood flow during primary PCI, and the diagnostic value of the combined indicator was superior to that of any single indicator, which could be used for the evaluation of slow blood flow during primary PCI, so as to evaluate the prognosis of patients with STEMI.